Feliza Mirasol is the science editor for 

Articles

Under the partnership, Sartorius will leverage SPARTA Biodiscovery’s technology to accelerate development of nanoparticles used for drug delivery.

Sartorius and SPARTA Biodiscovery Partner on Novel Nanoparticle Analysis Platform 

The contract is part of US Department of Health and Human Services’ ‘Project NextGen’ initiative, aimed at pushing forward new and stronger COVID-19 vaccines and therapies.

BARDA Awards Gritstone bio $433 Million Contract for Phase IIb Study of Next-Gen COVID-19 Vaccine

With the two new GMP-grade mRNA manufacturing sites in Germany, MilliporeSigma can now offer fully integrated mRNA services.

MilliporeSigma Opens Two New GMP Manufacturing Sites in Germany for mRNA Production

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Novo Nordisk’s obesity treatment has been so successful the company is now top of the ‘value pile’ in Europe.

Losing Weight, Gaining Value

The European Commission has granted approval for Tyruko (natalizumab), a biosimilar developed by Polpharma Biologics for treating multiple sclerosis.

EC Approves Polpharma Biologics’ MS-Treating Biosimilar

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

If the Alliance for mRNA Medicines (AMM) tested the waters in June 2023 at the BIO Conference in Boston, then they engaged in a full-fledged triathlon in September, in the heat and humidity of Washington, DC.

Washington, DC Houses mRNA Leadership

Mike Hennessy Jr. is the Chairman and CEO of 

It has been a long wait, but for Alzheimer’s at least, this is the beginning of renewed hope.

Renewed Hope for Alzheimer’s

The collaboration will provide easy access and transfer between data in Torx and CDD Vault, upping the efficiency of the small-molecule discovery process.

Torx Software and CDD Vault to Collaborate on Global Drug Discovery

The tools, originally utilized during the COVID-19 pandemic, are now intended to work alongside FDA’s standard procedures.

FDA Releases Guidance on Using Remote Oversight Tools for Drug Approval

The companies plan on targeting the production of abundant, low-cost messenger RNA from C1-cells.

News